drugset / Trial / NCT05167370

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

NCT05167370

Phase 2 Terminated 2 enrolled Children's Hospital Medical Center, Cincinnati
NaSingle-groupOpen-labelTreatment

Summary

This is a study of amifostine to determine how effective it is in the reduction of infection in a high dose chemotherapy regimen with autologous stem cell rescue in children with high risk, relapsed or refractory pediatric solid tumors.

Timeline

Start
2010-12-13
Primary completion
2011-04-29
Completion
2012-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown 1125 mg/m2 Intravenous

Indications